Atlas Trials

Effects of Atomoxetine in Mild Cognitive Impairment

Clinical trial NCT01522404 · COMPLETED

Trial details

NCT number
NCT01522404
Sponsor
Emory University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Mild Cognitive Impairment
Start date
2012-03-01
Primary completion
2017-10-31
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.